Abstracts Archive - Page 1468 of 2607 - ACR Meeting Abstracts

Abstract Number: 1211 • 2017 ACR/ARHP Annual Meeting
Biomarkers Predictive of Pain Improvement in Knee Osteoarthritis Subjects Treated with the Anti-IL-1α/β Dual Variable Domain Immunoglobulin ABT-981
Sheng Feng¹, Su Chen¹, Li Wang¹, Charles Peterfy², Virginia B. Kraus³, Rajesh Kamath¹, Lanju Zhang¹, Yanping Luo¹, Lu Cui¹, Jeroen K. Medema¹ and Marc C. Levesque¹, ¹AbbVie Inc., North Chicago, IL, ²Spire Sciences, Inc., Boca Raton, FL, ³Duke University School of Medicine, Durham, NC
Background/Purpose: Development of disease-modifying drugs for OA has been challenging, partly due to lack of predictive biomarkers. Our primary objective was to identify baseline (BL)…
Abstract Number: 1212 • 2017 ACR/ARHP Annual Meeting
Relation of Incident Bisphosphonate Use to Bone Marrow Lesion Volume in Knee Osteoarthritis
Tuhina Neogi¹, Jeffrey Duryea², Na Lu¹, Jingbo Niu¹ and Yuqing Zhang¹, ¹Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, ²Radiology, Brigham & Women's Hospital/ Harvard Medical School, Boston, MA
Background/Purpose: Bone marrow lesions (BMLs) are important contributors to pain and progression of knee OA. There has been recent interest in bisphosphonates as a potential…
Abstract Number: 1213 • 2017 ACR/ARHP Annual Meeting
Prediction Model for the Two-Year Risk of Fracture Among Older US Women
Annette Adams¹, Akhila Balasubramanian², Hui Zhou³, Robert Platt⁴, Deborah Wenkert⁵, Steven Jacobsen³ and Eric Johnson⁶, ¹Kaiser Permanente Southern California, Pasadean, CA, ²Amgen Inc., Thousand Oaks, CA, ³Kaiser Permanente Southern California, Pasadena, CA, ⁴McGill University, Montreal, QC, Canada, ⁵Wenkert & Young, LLC, Thousand Oaks, CA, ⁶Kaiser Permanente Northwest, Portland, OR
Background/Purpose: Current algorithms for identifying patients at high risk of fracture focus on long-term risk. We developed simple 10- and 3-predictor models and points-based risk…
Abstract Number: 1214 • 2017 ACR/ARHP Annual Meeting
Fracture Incidence and Characteristics in Young Adults Age 18 to 49 Years: A Population-Based Study
Joshua N. Farr¹, L. Joseph Melton III¹, Sara J. Achenbach¹, Elizabeth J. Atkinson¹, Sundeep Khosla¹ and Shreyasee Amin², ¹Mayo Clinic, Rochester, MN, ²Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: While fractures in both the elderly and pediatric populations have been extensively investigated, comparatively little attention has been given to the age-group in between.…
Abstract Number: 1215 • 2017 ACR/ARHP Annual Meeting
Chest Radiography As a Screening Tool to Detect Fragile Spine Fractures
Yasuhiro Suyama¹, Mitsumasa Kishimoto², Taiki Nozaki³, Tetsuhiko Okabe⁴ and Masato Okada², ¹Rheumatology, JR Tokyo General Hospital, Tokyo, Japan, ²Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan, ³Radiology, St. Luke’s International Hospital, Tokyo, Japan, ⁴Radiology, Yokohama City University, Yokohama, Japan
Background/Purpose: Osteoporosis screening is essential in the management of rheumatoid arthritis, and evaluation of fragile spine fractures is one of the recommended examinations. Digital chest…
Abstract Number: 1216 • 2017 ACR/ARHP Annual Meeting
Odontoid Fractures in the Elderly: An Unknown Osteoporotic Fracture?
Veronique Breuil¹, Lauren Natella², Nicolas Bronsard³, Jeremy Allia³, Laurent Hekayem⁴, Liana Euller Ziegler⁵ and Fernand De Peretti⁶, ¹Rheumatology department, Nice, France, ²Rheumatology, CHU Nice, nice, France, ³Orthopedic, CHU Nice, Nice, France, ⁴Emergency, CHU Nice, Nice, France, ⁵151 rte de St Antoine de Gines, CHU de Nice -Université Nice Sophia Antipolis, Nice, France, ⁶orthopedic, CHU Nice, Nice, France
Background/Purpose: Current WHO definition of osteoporosis excludes cervical fractures. However, in atraumatic odontoid fractures, mainly reported by orthopedic surgeons, bone status has not been described…
Abstract Number: 1217 • 2017 ACR/ARHP Annual Meeting
Evaluation of Post Fracture Management in Males at a Veterans Affairs Health System
Nicola Berman¹, David Smith², Virginia Pike³, Craig Tenner⁴, Michael Pillinger¹ and Stephen Honig¹, ¹Rheumatology, New York University School of Medicine, Division of Rheumatology, New York, NY, ²School of Medicine, New York University School of Medicine, New York, NY, ³Medicine/Rheumatology, New York University School of Medicine, Division of Rheumatology, New York, NY, ⁴New York University School of Medicine, Internal Medicine, New York, NY
Background/Purpose: The worldwide incidence of hip fractures in men is rising, and by 2050 is projected to increase by 310%. Increased hip fracture rates may…
Abstract Number: 1218 • 2017 ACR/ARHP Annual Meeting
Caffeine Consumption and Risk of Osteoporosis: A Cross Sectional Study of 3, 210 Patients from the National Health and Nutrition Examination Survey
Nicola Berman¹, Teresa Attina², Bruce Cronstein¹, Stephen Honig¹ and Michael Pillinger¹, ¹Rheumatology, New York University School of Medicine, Division of Rheumatology, New York, NY, ²Pediatrics, New York University School of Medicine, New York, NY
Background/Purpose: Adenosine regulates bone metabolism. In vitro studies suggest that direct stimulation of the adenosine A2A receptor increases osteoblasts and diminishes osteoclasts, and thus inhibition…
Abstract Number: 1219 • 2017 ACR/ARHP Annual Meeting
Associations between Muscle Mass and Function with Bone Microarchitecture and Bone Strength in Postmenopausal Women
Daniel Lobo¹, Jackeline C Alvarenga¹, Diogo S Domiciano², Fabiana Benatti¹, Bruno Gualano¹ and Rosa M R Pereira², ¹Rheumatology Division, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil, ²Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil
Background/Purpose: Most studies on sarcopenia and osteoporosis involve elderly populations. However, because postmenopausal hypoestrogenism is able to negatively modulate bone and muscle mass, it is…
Abstract Number: 1220 • 2017 ACR/ARHP Annual Meeting
Effect of Anti-Diabetic Medications on Fracture Risk in Type II Diabetes Mellitus
Youmna Lahoud¹, Christine Peloquin¹, Yuqing Zhang² and Devyani Misra³, ¹Boston University School of Medicine, Boston, MA, ²School Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ³Medicine, Section of, Boston University School of Medicine, Boston, MA
Background/Purpose: Risk of osteoporotic fracture in type II Diabetes Mellitus is conflicting and possibly related to the anti-diabetic medication used. There is evidence to suggest…
Abstract Number: 1221 • 2017 ACR/ARHP Annual Meeting
Differences in BONE Metabolism between Intermittent and Continuous Treatment with LHRH Agonists in Prostate Cancer Patients
Karla Arevalo Ruales¹, Jose Ivorra Cortes¹, Cesar David Vera Donoso², Elena Grau Garcia¹, Cristina Alcañiz Escandell¹, Ines Canovas Olmos¹, Inmaculada Chalmeta Verdejo¹, Carlos Feced Olmos¹, Jorge Juan Fragio Gil¹, Roxana Gonzalez Mazario¹, Luis Gonzalez Puig¹, Eztizen Labrador Sanchez¹, Isabel Martinez Cordellat¹, Carmen Najera Herranz¹, Rosa Negueroles Albuixech¹, Jose Eloy Oller Rodriguez¹, Francisco Miguel Ortiz-Sanjuán¹, Elvira Vicens Bernabeu¹, David Hervás Marín³, Marta De la Rubia Navarro¹ and Jose Andres Roman Ivorra¹, ¹Rheumatology Department. Hospital Universitario y Politecnico La Fe, Valencia, Spain, ²Urology Department. Hospital Universitario y Politecnico La Fe, Valencia, Spain, ³Biostatistics Unit. IIS La Fe, Valencia, Spain
Background/Purpose: Prostate cancer is the most common male malignancy. It is hormone dependent and androgenic inhibition with LHRH agonists is one of the mainstays of…
Abstract Number: 1222 • 2017 ACR/ARHP Annual Meeting
Impact of Bariatric Surgery on Bone Mineral Density : Observational Study of 110 Patients Followed up in a Specialised Centre for the Treatment of Obesity in France
Marion Geoffroy¹, Isabelle Lambrecht¹, Jan Chrusciel², Isabelle Gaubil-Kaladjian³, Ana Diaz-Cives⁴, Jean Paul Eschard¹ and Jean-Hugues Salmon¹, ¹Service de Rhumatologie, CHU Reims, Hôpital Maison Blanche, Reims, France, ²Service de Recherche Clinique, CHU Reims, Hôpital Robert Debré, Reims, France, ³Service d’Endocrinologie et nutrition, CHU Reims, Hôpital Robert Debré, Reims, France, ⁴Service de chirurgie digestive, CHU Reims, Hôpital Robert Debré, Reims, France
Background/Purpose: Bariatric surgery is used to treat severe obesity. We aimed to investigate the incidence of significant bone mineral density (BMD) loss at 6 and…
Abstract Number: 1223 • 2017 ACR/ARHP Annual Meeting
Inflammatory Bowel Diseases and the Risks of Fracture and Low Mineral Density: Review of the Literature and Meta-Analysis of Observational Cohorts
Paulina Szafors¹, Thomas Barnetche², Cédric Lukas³, Jacques Morel⁴, Cécile Gaujoux-Viala^5,6, Bernard Combe⁷ and Hélène Che⁸, ¹Department of Rheumatology, Lapeyronie Hospital and University of Montpellier, Montpellier, France, ²Rheumatology Department, Pellegrin University Hospital, BORDEAUX, France, ³Rheumatology, CHU Lapeyronie and EA2415, Montpellier University, University of Montpellier, France, ⁴Rheumatology, CHU Lapeyronie and Montpellier University, Montpellier, France, ⁵Rheumatology, Nîmes University Hospital and EA2415 Montpellier University, Nîmes, France, ⁶EA 2415, Montpellier University, Nîmes, France, ⁷Department of rheumatology, Lapeyronie Hospital and Montpellier University, Montpellier, France, ⁸Rheumatology, University and Hospital Lapeyronie, University of Montpellier, France
Background/Purpose: Inflammatory bowel diseases (IBD), such as Crohn disease (CD) and ulcerative colitis (UC), are associated with a decreased bone mineral density caused by chronic…
Abstract Number: 1224 • 2017 ACR/ARHP Annual Meeting
BONE Metabolism in LIVER Transplant Patients Two-Year Study. Influence of Medical Intervention PRIOR to Surgery and Antiresorptive Treatment
Eztizen Labrador Sanchez¹, Elena Grau Garcia¹, Karla Arevalo Ruales¹, Jorge Juan Fragio Gil¹, Roxana Gonzalez Mazario¹, Cristina Alcañiz Escandell¹, Ines Canovas Olmos¹, Inmaculada Chalmeta Verdejo¹, Carlos Feced Olmos¹, Luis Gonzalez Puig¹, Jose Ivorra Cortes¹, Isabel Martinez Cordellat¹, Carmen Najera Herranz¹, Rosa Negueroles Albuixech¹, Jose Eloy Oller Rodriguez¹, Francisco Miguel Ortiz-Sanjuán¹, Elvira Vicens Bernabeu¹, Victoria Fornes Ferrer², David Hervás Marín², Marta De la Rubia Navarro¹, Angel Moya Herraiz³ and Jose Andres Roman Ivorra¹, ¹Rheumatology Department. Hospital Universitario y Politecnico La Fe, Valencia, Spain, ²Biostatistics Unit. IIS La Fe, Valencia, Spain, ³Hepatology Department. Hospital Universitario y politecnico La Fe, Valencia, Spain
Background/Purpose: Osteoporosis is a frequent complication in patients with chronic liver diseases, mainly in advanced stages or with evidence of cholestasis. During the first few…
Abstract Number: 1225 • 2017 ACR/ARHP Annual Meeting
BONE Mineral Density and Vertebral Fractures in Gaucher Disease Patients Treated with Imiglucerase
Maria Silvia Larroude¹, Gabriel Aguilar¹, Ignacio Rossi¹, Lucas Ricardo Brun² and Guillermo Drelichman³, ¹Centro de Diagnostico Rossi, Buenos Aires, Argentina, ²School of Medicine. Rosario National University, Bone Biology Laboratory, Rosario, Argentina, ³Hospital Ricardo Gutierrez, Buenos Aires, Argentina
Background/Purpose: Osteopenia and osteoporosis (OP) have been described in patients with Gaucher disease (GD) but there are very few reports about bone mass in GD…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].